Miguel Ángel Rodríguez-Weber
Biographic Data
| ID | 9999791 |
|---|---|
| NAME | Miguel Ángel Rodríguez-Weber |
| GIVEN NAMES | Miguel Ángel |
| FAMILY NAME | Rodríguez-Weber |
| SIGNATURE | RODRÍGUEZ-WEBER M Á |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules
Introduction Rotavirus-associated diarrheal diseases significantly burden healthcare systems, particularly affecting infants under five years. Both RotarixTM (RV1) and RotaTeqTM (RV5) vaccines have been effective but have distinct application schedules and limited interchangeability data. This study aims to provide evidence on the immunogenicity, reactogenicity, and safety of mixed RV1-RV5 schedules compared to their standard counterparts. Method…
No prominent works on this page.
Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules
Introduction Rotavirus-associated diarrheal diseases significantly burden healthcare systems, particularly affecting infants under five years. Both RotarixTM (RV1) and RotaTeqTM (RV5) vaccines have been effective but have distinct application schedules and limited interchangeability data. This study aims to provide evidence on the immunogenicity, reactogenicity, and safety of mixed RV1-RV5 schedules compared to their standard counterparts. Method…
Adverse effect (1 work) · Antibody (1 work) · Cohort (1 work) · Immunogenicity (1 work) · Immunology (1 work) · Infant Nutrition and Health (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Pediatrics (1 work) · Randomized controlled trial (1 work)